Genmab | GEN - Stock



Genmab reported DKK13M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Agios Pharmaceuticals USD 30.85M 1.24M Jun/2025
Almirall EUR 180.5M 8.81M Mar/2025
Amarin USD 224M 15.41M Sep/2024
Amgen USD 6.58B 146M Jun/2025
argenx SE USD 340.62M 66.61M Jun/2025
AstraZeneca USD 6.47B 583M Jun/2025
Bayer EUR 12.11B 576M Jun/2025
BioMarin Pharmaceutical USD 1.34B 65.32M Jun/2025
Demant DKK 2.54B 42M Jun/2025
Exelixis USD 23.48M 1.37M Jun/2025
Fresenius Medical Care EUR 2B 82.67M Jun/2025
Galapagos EUR 38.52M 12.67M Mar/2025
Genmab DKK 13M 1000K Jun/2025
GlaxoSmithKline GBP 6.07B 72M Jun/2025
GN Store Nord DKK 2.57B 13M Mar/2025
GRIFOLS EUR 3.35B 213.23M Jun/2025
Hikma Pharmaceutical USD 986M 50M Dec/2024
Insmed USD 107.6M 6.89M Jun/2025
Lonza CHF 1.73B 13M Dec/2024
Merck EUR 4.47B 45M Jun/2025
Novartis USD 6.31B 478M Jun/2025
Regeneron Pharmaceuticals USD 3.21B 760.7M Jun/2025
Roche Holding CHF 7.61B 339M Dec/2024
Sanofi EUR 9.62B 12.23B Jun/2025
UCB 1.31B 173M Dec/2024